1. Home
  2. CIF vs CASI Comparison

CIF vs CASI Comparison

Compare CIF & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIF
  • CASI
  • Stock Information
  • Founded
  • CIF 1988
  • CASI 1991
  • Country
  • CIF United States
  • CASI China
  • Employees
  • CIF N/A
  • CASI N/A
  • Industry
  • CIF Trusts Except Educational Religious and Charitable
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIF Finance
  • CASI Health Care
  • Exchange
  • CIF Nasdaq
  • CASI Nasdaq
  • Market Cap
  • CIF 31.1M
  • CASI 24.9M
  • IPO Year
  • CIF N/A
  • CASI 1996
  • Fundamental
  • Price
  • CIF $1.74
  • CASI $1.04
  • Analyst Decision
  • CIF
  • CASI Strong Buy
  • Analyst Count
  • CIF 0
  • CASI 1
  • Target Price
  • CIF N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • CIF 43.9K
  • CASI 23.3K
  • Earning Date
  • CIF 01-01-0001
  • CASI 11-14-2025
  • Dividend Yield
  • CIF 10.11%
  • CASI N/A
  • EPS Growth
  • CIF N/A
  • CASI N/A
  • EPS
  • CIF N/A
  • CASI N/A
  • Revenue
  • CIF N/A
  • CASI $26,846,000.00
  • Revenue This Year
  • CIF N/A
  • CASI N/A
  • Revenue Next Year
  • CIF N/A
  • CASI N/A
  • P/E Ratio
  • CIF N/A
  • CASI N/A
  • Revenue Growth
  • CIF N/A
  • CASI 21.72
  • 52 Week Low
  • CIF $1.47
  • CASI $1.01
  • 52 Week High
  • CIF $1.77
  • CASI $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CIF 55.98
  • CASI 28.56
  • Support Level
  • CIF $1.68
  • CASI $1.01
  • Resistance Level
  • CIF $1.71
  • CASI $1.25
  • Average True Range (ATR)
  • CIF 0.02
  • CASI 0.10
  • MACD
  • CIF 0.00
  • CASI -0.01
  • Stochastic Oscillator
  • CIF 78.57
  • CASI 4.26

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: